From: Retrospective clinical study of ultrawide implants more than 6 mm in diameter
Length (mm) | 7.0 | 8.0 | 10.0 | 12.0 | P value | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Mean | SD | N | Mean | SD | N | Mean | SD | N | Mean | SD | ||
Survival rate | 6 | 100 % | 0.00 | 21 | 100 % | 0.00 | 23 | 100 % | 0.00 | 8 | 87.50 % | 0.35 | NS |
Success rate | 6 | 100 % | 0.00 | 21 | 95.24 % | 0.22 | 23 | 95.65 % | 0.21 | 8 | 87.50 % | 0.35 | NS |
Primary stability | 6 | 77.33 | 9.77 | 21 | 72.14 | 10.10 | 23 | 75.52 | 9.27 | 8 | 65.25 | 7.40 | + |
Secondary stability | 6 | 84.42 | 3.50 | 17 | 76.85 | 8.59 | 17 | 78.97 | 8.45 | 7 | 69.43 | 9.48 | + |
Marginal bone loss | |||||||||||||
12 months | 5 | 0.00 | 0.00 | 21 | 0.02 | 0.10 | 21 | 0.00 | 0.00 | 7 | 0.08 | 0.20 | NS |
24 months | 4 | 0.00 | 0.00 | 16 | 0.00 | 0.00 | 16 | 0.03 | 0.09 | 6 | 0.25 | 0.60 | NS |
Marginal bone lossa | 6 | 0.00 % | 0.00 | 21 | 4.76 % | 0.22 | 23 | 4.35 % | 0.22 | 8 | 12.50 % | 0.35 | NS |